Levin Capital Strategies, L.P. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Levin Capital Strategies, L.P.

  • $1.03 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 17, 2020
SELL
$59.04 - $77.95 $1.67 Million - $2.21 Million
-28,315 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$29.01 - $74.23 $241,073 - $616,851
-8,310 Reduced 22.69%
28,315 $2.07 Million
Q1 2020

May 13, 2020
BUY
$27.51 - $57.29 $649,923 - $1.35 Million
23,625 Added 181.73%
36,625 $1.25 Million
Q4 2019

Feb 10, 2020
BUY
$40.86 - $57.65 $531,180 - $749,450
13,000 New
13,000 $708,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.39B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Levin Capital Strategies, L.P. Portfolio

Follow Levin Capital Strategies, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email